Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

(2011) D. E. Reece et al.   BLOOD

Amyloidosis: Pathogenesis and New Therapeutic Options

(2011) Giampaolo Merlini et al.   JOURNAL OF CLINICAL ONCOLOGY

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010

(2010) J. Blade et al.   BLOOD

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

(2010) M A Gertz et al.   BONE MARROW TRANSPLANTATION

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

(2010) Morie A. Gertz et al.   LEUKEMIA & LYMPHOMA